After the year started off with more than 200 transplants a month, only 23 have been performed in April. “My fear is that we will see an increase in deaths on the waitlist because of the lack of availability for an organ right now,” said the director of an organ-procurement service. Other public health news reports on another rise in anti-semitic sentiment, more home births, rising anxiety, tips on communicating with your 24/7 partner and pleas to remember dangers of climate change on Earth Day, as well.
from Kaiser Health News https://ift.tt/2yBOrtJ
April 21, 2020
Rose
Health News, Kaiser Health News
No comments
Related Posts:
How Unconscious Physician Biases About Race, Ethnicity And Pain Plays A Role In The Opioid CrisisA new study reveals that residents of neighborhoods with the highest proportions of white people were more than twice as likely to be prescribed an opioid pain reliever than were residents of neighborhoods where whites were m… Read More
Where Is The Line Between Getting A Suicidal Person Help And Their Right To Privacy? Experts Wonder If Facebook Is Toeing It“It’s important to have innovative approaches. But just because people are suicidal and in crisis doesn’t mean they don’t deserve rights,” said Dr. John Torous, the director of the digital psychiatry division at Beth Israel D… Read More
With New Rules To Give Patients Better Access To Own Records, CMS Takes Aim At ‘Electronic Silos’ That Keep Health Data SeparatedThe draft rules touch on a broad array of issues, including technology standards that are supposed to help unlock digital data stored in the electronic health records used by hospitals and doctors to track patients’ care. Mea… Read More
Migrant Families Separated By U.S. Government File Claims For Millions In DamagesEight separated families submitted claims to the departments of Homeland Security and Health and Human Services, saying that their children were traumatized by the experience. Stanton Jones, a lawyer for the families, said, “… Read More
Pharma Companies Dramatically Slash List Price For Cholesterol Drug In Rare MoveRival cholesterol drugs Praluent and Repatha have struggled as insurance companies and benefit managers have made it difficult for patients to get the treatment. Because they were so expensive, even for patients with a geneti… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment